Navigation Links
DRAXIS Health Reports Fourth Quarter and Year End Results
Date:2/7/2008

of 2007 compared to the significant lower

levels of the third quarter of 2007. Nevertheless, as expected,

Hectorol(R) volumes did not achieve the record levels of 2006 and in

particular the fourth quarter of 2006.

Included in this segment's revenues for the quarter are

approximately $0.9 million ($2.6 million for 2007) in product

transfer activities related to the Company's new Johnson & Johnson

Consumer contract.

- Product gross margin percentage decreased to 27% in the fourth

quarter and to 24% for 2007 compared to 39% and 36%, respectively,

for the same periods of 2006. The decrease was driven by lower

sterile volumes impacting margins through lower plant utilization

and a lower percentage of sterile volumes as part of the overall

product mix.

- Operating income for the fourth quarter of 2007 was $0.2 million and

for 2007 was $2.6 million compared to operating income of

$4.2 million and $13.0 million respectively for the same periods in

2006 due to lower sterile volumes and increased severance costs,

partially offset by a revaluation of incentive awards.

- During the fourth quarter of 2007, the contract manufacturing

division continued to implement procedures to reduce production

delays that have in the past resulted in shipments not being

released in a timely manner, impacting quarterly results for most of

2007. While the Company has made improvements in expediting the

process times for orders, shifting customer shipment schedules and

reprioritizing projects associated with organizational changes, the

improvements have to date only partially removed the backlog of

built-up demand. The procedures being put in place to remove the

backlog of demand and to improve t
'/>"/>

SOURCE DRAXIS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
2. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
3. DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin as President and Chief Executive Officer
4. DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
5. DRAXIS Announces Application for Normal Course Issuer Bid
6. DRAXIS Share Buyback Approved by TSX
7. DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. UCLA researchers identify markers that may predict diabetes in still-healthy people
10. Air pollution linked to cardiovascular risk indices in healthy young adults
11. More proof needed of safety and quality of electronic personal health records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... San Diego, Calif. (April 18, 2014) ― A new ... analyzing weekly patterns in health-related Google searches reveals ... public health strategies. , Investigators from San ... University, and the Monday Campaigns, analyzed "healthy" Google searches ... health-related, e.g., "healthy diet") originating in the U.S. from ...
(Date:4/17/2014)... The presence of chronic inflammation in benign ... prostate cancer, and this association was found even ... according to a study published in Cancer ... the American Association for Cancer Research. , An ... participants of the placebo arm of the Prostate ...
(Date:4/17/2014)... that could be used to provide relief from ... made the discovery when researching how pain occurs ... , Dr Marzia Malcangio said: "We have been ... our findings could help chemotherapy patients who suffer ... effect of some chemotherapy drugs (such as vincristine) ...
(Date:4/17/2014)... In the April issue of Experimental Biology ... by Drs. Rex Gaskins and Paul Kenis in ... campus of the University of Illinois Urbana-Champaign describe ... reduction-oxidation reactions underlie a variety of cell functions ... to these crucial roles in regulating normal cellular ...
(Date:4/17/2014)... the April issue of Immunity , Kevin J. ... Research, says it,s time to take a fresh look ... sepsis, which kills millions worldwide every year, including more ... into the bloodstream to fight an injury or infection ... maintaining good health without inflammation, wounds and infections ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... Analyzer and VetScan Canine Heartworm Rapid Test at the ... 16 Abaxis, Inc. (Nasdaq: ABAX ... instruments for both the medical and veterinary markets, announced ... Coagulation Analyzer and VetScan Canine Heartworm Rapid Test ...
... Direct Sales Model in Guangdong ProvincePROVO, Utah, Jan. 15 ... ) announced today that it has received official notification ... to commence direct selling activities in four cities in ... approval gives Nu Skin Enterprises the opportunity to offer ...
... cognition suffers as nervous system network decays with aging ... matter" that connects the regions of the brain may ... loss than previously believed, a new study says. ... healthy young and old adults, Massachusetts Institute of Technology ...
... Mich., Jan. 15 Dr. Brett Kotlus is the,first ... and,tissue glue to lift the brow for facial rejuvenation. ... brow-lifting techniques. Cosmetic,surgeons are using multiple new medical devices ... Kotlus, of Allure Medical Spa, presented his ...
... /PRNewswire-FirstCall/ - QLT Inc. ("QLT") (NASDAQ: QLTI ; ... its modified "Dutch Auction" tender offer (the "Offer") for up ... on December 5, 2008. The Offer, which was to expire ... 5:00 p.m. (Eastern time) on January 26, 2009, unless further ...
... to Be Held on Martin Luther King Day in ... DC at the Martin Luther King Library ... relief organization, announced today that on Martin Luther King Jr. Day, ... against hunger with Martin Luther King III, David Arquette, and musical ...
Cached Medicine News:Health News:ABAXIS Announces Launch of Two New Products at the NAVC 2Health News:ABAXIS Announces Launch of Two New Products at the NAVC 3Health News:Nu Skin Enterprises Receives Broader Direct Selling Authorization in China 2Health News:Looking Years Younger, Raising a Few Brows 2Health News:QLT announces new expiration date of tender offer 2Health News:QLT announces new expiration date of tender offer 3Health News:Feeding America, Martin Luther King III, David Arquette, Josh Groban and Herbie Hancock Join Forces to Combat Hunger in America on Presidential Inaugural Committee National Day of Service 2Health News:Feeding America, Martin Luther King III, David Arquette, Josh Groban and Herbie Hancock Join Forces to Combat Hunger in America on Presidential Inaugural Committee National Day of Service 3
(Date:1/15/2014)... WASHINGTON , Jan. 15, 2014 AARP Foundation today ... support older adults suffering from the severe cold weather that ... are committed to helping those in need; so to support ... dollar-for-dollar contributions up to $250,000, which could mean up to ...
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Texas--(BUSINESS WIRE)--Apr 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:RPRX) ... of Proellex(TM), an oral drug being developed to,relieve ... with Proellex results in a statistically highly,significant improvement ... well tolerated., Study Details and Results , This ...
... Arrowhead Research,Corporation (NASDAQ: ARWR) announced the publication ... a study,demonstrating the anti-proliferative effect of the ... its lead anti-cancer,compound, CALAA-01., The paper, entitled ... Reduce Cell Proliferation In vitro and In,vivo", ...
Cached Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 2Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study,Showing Anti-Cancer Effect with Lead RNAi Candidate 3
Incontinence Pessaries...
Incontinence Dish - Stress Incontinence with mild prolapse. Incontinence Dish with support - Stress Incontinence with mild prolapse and mild cystocele...
The donut pessary is designed for third degree prolapse as well as cystocele and rectocele. The soft donut can be compressed for insertion. It is available in seven sizes....
The Incontinence Dish is used to relieve stress incontinence and minor degrees of prolapse. The Incontinence Dish comes with and without support. It is available in eight different sizes....
Medicine Products: